Heron Therapeutics Inc (HRTX)

Cost of Revenue

$45.24M

TTM · Period ending: · USD

HRTX logo

HRTX Cost of Revenue

Latest reported$45.24M
HRTX TTM Cost of Revenue ($0.00 → $45.24M)
High-resolution chart · PNG

HRTX cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Heron Therapeutics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
45,243,000
43,528,000
41,347,000
43,926,000
38,000,000
38,661,000
38,648,000
38,305,000
47,055,000
56,695,000
65,105,000
67,847,000
64,356,000
60,373,000
54,874,000
53,188,000
49,822,000
48,169,000
46,021,000
44,472,000
40,291,000
34,774,000
36,189,000
42,671,000
52,696,000
57,279,000
61,619,000
57,317,000
47,698,000
39,341,000
27,512,000
17,278,000
10,753,000
6,535,000
4,588,000
3,285,000
32,476,000
58,749,000
73,655,000
89,883,000
73,882,000
62,771,000
61,183,000
57,399,000
57,889,000
55,993,000
53,117,000
47,392,000
38,877,000
35,404,000
30,916,000
29,314,000
26,724,000
15,918,000
8,778,000
3,626,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
114,000
223,000
331,000
444,910
477,200
455,541
460,860
440,270
603,060
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.